Gemcabene
Sponsors
NeuroBo Pharmaceuticals Inc., Emory University
Conditions
HypercholesteremiaHypercholesterolemiaMixed DyslipidaemiaNon-Alcoholic Fatty Liver DiseaseSevere Hypertriglyceridemia
Phase 2
Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients on Stable Statin Therapy
CompletedNCT02571257
Start: 2000-08-31End: 2002-04-30Updated: 2020-04-09
Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients as Monotherapy or in Combination With Atorvastatin
CompletedNCT02591836
Start: 2003-01-31End: 2003-06-30Updated: 2020-04-09
A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins
CompletedNCT02634151
Start: 2016-11-30End: 2017-08-31Updated: 2020-06-25
Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lowering Therapy (COBALT-1)
CompletedNCT02722408
Start: 2016-06-30End: 2017-07-31Updated: 2020-06-25
A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia
CompletedNCT02944383
Start: 2016-12-31End: 2018-05-09Updated: 2020-06-25
Gemcabene for the Treatment of Pediatric NAFLD
TerminatedNCT03436420
Start: 2018-03-29End: 2019-08-27Updated: 2020-12-31